share_log

Aeglea Bio Therapeutics On Jan 13 Got Notice From Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement For Continued Listing On Nasdaq

Benzinga Real-time News ·  Jan 18, 2023 07:17
Aeglea Bio Therapeutics On Jan 13 Got Notice From Nasdaq That Co No Longer Complies With Minimum Bid Price Requirement For Continued Listing On Nasdaq
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment